| Literature DB >> 31766649 |
Noelia Pallarés1, Dionisia Carballo2, Emilia Ferrer1, Mónica Fernández-Franzón1, Houda Berrada1.
Abstract
Consumption of fruit juice is becoming trendy for consumers seeking freshness and high vitamin and low caloric intake. Mycotoxigenic moulds may infect fruits during crop growth, harvest, and storage leading to mycotoxin production. Many mycotoxins are resistant to food processing, which make their presence in the final juice product very likely expected. In this way, the presence of 30 mycotoxins including aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin G1 (AFG1), aflatoxin G2 (AFG2), alternariol (AOH), alternariol monomethyl ether (AME), Ochratoxin A (OTA), fumonisin B1 (FB1), fumonisin B2 (FB2), enniatin A (ENNA), enniatin A1 (ENNA1), enniatin B (ENNB), enniatin B1 (ENNB1), beauvericin (BEA), sterigmatocystin (STG), zearalenone (ZEA), α-zearalanol (α-ZAL), β-zearalanol (β-ZAL), α-zearalenol (α-ZOL), β-zearalenol (β-ZOL), deoxynivalenol (DON), 3-acetyl-deoxynivalenol (3-ADON), 15-acetyl-deoxynivalenol (15-ADON), diacetoxyscirpenol (DAS), nivalenol (NIV), fusarenon-X (FUS-X), neosolaniol (NEO), patulin (PAT), T-2 toxin and HT-2 toxin was evaluated in 80 juice samples collected from Valencia retail Market. An efficient Dispersive Liquid-Liquid Microextraction method (DLLME) was carried out before their trace level determination by chromatographic techniques coupled to tandem mass spectrometry. The results obtained revealed the presence of nine mycotoxins namely AOH, AME, PAT, OTA, AFB1, AFB2, AFG2, β-ZAL, and HT2 in the analyzed samples, with incidences ranging from 3 to 29% and mean contents between 0.14 and 59.52 µg/L. Considerable percentages of TDIs were reached by children when 200 mL was considered as daily fruit juice intake.Entities:
Keywords: DLLME; fruit juice; mycotoxins; risk assessment
Mesh:
Substances:
Year: 2019 PMID: 31766649 PMCID: PMC6950291 DOI: 10.3390/toxins11120684
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Quantification and confirmation transitions of mycotoxins monitored fragments, retention time (Rt)) and analytical parameters obtained.
| Mycotoxin | Quantification Transition | Confirmation Transition | Rt | SSE (%) c | LOD | LOQ | Recovery (%) | ||
|---|---|---|---|---|---|---|---|---|---|
| 50 | 100 | 200 | |||||||
| m/z | m/z | min | µg/L | µg/L | µg/L | µg/L | µg/L | ||
| ZEA a | 462 > 151 | 462 > 333 | 15.95 | 115 | 2.34 | 7.81 | 98 | 113 | 103 |
| α-ZAL a | 433 > 309 | 433 > 295 | 15.45 | 88 | 0.58 | 1.95 | 101 | 97 | 99 |
| β-ZAL a | 433 > 295 | 307 > 73 | 15.68 | 91 | 2.34 | 7.81 | 97 | 105 | 104 |
| α-ZOL a | 305 > 73 | 305 > 289 | 16.45 | 62 | 0.58 | 1.95 | 80 | 113 | 95 |
| β-ZOL a | 536 > 333 | 536 > 446 | 16.82 | 69 | 1.17 | 3.90 | 98 | 102 | 69 |
| DON a | 392 > 259 | 407 > 197 | 8.4 | 103 | 0.58 | 1.95 | 68 | 72 | 63 |
| 3-ADON a | 392 > 287 | 467 > 147 | 9.68 | 88 | 1.17 | 3.90 | 103 | 103 | 105 |
| 15-ADON a | 392 > 217 | 392 > 184 | 9.65 | 114 | 0.58 | 1.95 | 95 | 98 | 96 |
| DAS a | 350 > 229 | 378 > 124 | 9.85 | 96 | 1.17 | 3.90 | 103 | 91 | 84 |
| NIV a | 289 > 73 | 379 > 73 | 10.15 | 87 | 1.17 | 3.90 | 61 | 88 | 97 |
| FUS-X a | 450 > 260 | 450 > 245 | 9.73 | 106 | 2.34 | 7.81 | 84 | 98 | 106 |
| NEO a | 252 > 195 | 252 > 167 | 11.68 | 95 | 0.58 | 1.95 | 83 | 71 | 69 |
| PAT a | 226 > 73 | 183 > 75 | 4.3 | 78 | 2.34 | 7.81 | 61 | 96 | 92 |
| T-2 a | 350 > 259 | 350 > 229 | 14.8 | 71 | 2.34 | 7.81 | 98 | 96 | 71 |
| HT-2 a | 347 > 157 | 347 > 185 | 14.39 | 78 | 0.58 | 1.95 | 106 | 107 | 78 |
| AFB1 b | 313 > 285 | 313 > 241 | 7.41 | 48 | 0.3 | 1.0 | 111 | 64 | 115 |
| AFB2 b | 315 > 287 | 315 > 259 | 7.36 | 80 | 0.3 | 1.0 | 83 | 71 | 69 |
| AFG1 b | 329 > 243 | 329 > 311 | 7.23 | 60 | 0.3 | 1.0 | 63 | 76 | 83 |
| AFG2 b | 331 > 313 | 331 > 245 | 7.13 | 41 | 0.3 | 1.0 | 79 | 70 | 92 |
| AOH b | 259 ˃ 128 | 258 ˃ 184 | 8.01 | 67 | 0.3 | 1.0 | 105 | 114 | 90 |
| AME b | 273 ˃ 128 | 273 ˃ 228 | 9.10 | 120 | 0.3 | 1.0 | 78 | 89 | 71 |
| OTA b | 404 > 239 | 404 > 102 | 8.68 | 64 | 0.3 | 1.0 | 90 | 73 | 71 |
| FB1 b | 722 ˃ 334 | 722 ˃ 352 | 7.7 | 75 | 1.5 | 5.0 | 65 | 86 | 82 |
| FB2 b | 706 ˃ 336 | 706 ˃ 318 | 7.85 | 67 | 1.5 | 5.0 | 75 | 94 | 79 |
| ENNA b | 699 > 210 | 699 > 228 | 11.74 | 73 | 0.3 | 1.0 | 96 | 67 | 78 |
| ENNA1 b | 685 > 210 | 685 > 214 | 11.3 | 60 | 0.3 | 1.0 | 109 | 66 | 87 |
| ENNB b | 657 > 196 | 657 > 214 | 10.73 | 66 | 0.15 | 0.5 | 104 | 66 | 85 |
| ENNB1 b | 671 > 214 | 671 > 228 | 10.68 | 54 | 0.3 | 1.0 | 110 | 67 | 81 |
| BEA b | 801 > 784 | 801 > 244 | 10.84 | 52 | 1.5 | 5.0 | 112 | 65 | 82 |
| STG b | 325 > 281 | 325 > 310 | 9.08 | 106 | 1.5 | 5.0 | 62 | 66 | 71 |
a GC-MS/MS determination. b LC-MS/MS determination. c SSE: Signal Suppression-Enhancer.
Mycotoxins ranges and means found in the analyzed samples (μg/L).
| MYCOTOXIN | Mean of Positive Samples | Minimum Concentration | Maximum Concentration | Incidence (%) | Lower Bound Scenario a | Upper Bound Scenario b |
|---|---|---|---|---|---|---|
| AFB1 | 9.36 | 4.68 | 18.1 | 4 | 0.35 | 0.64 |
| AFB2 | 4.49 | 1.38 | 12.49 | 6 | 0.28 | 0.56 |
| AFG2 | 3.75 | 1.24 | 7.60 | 4 | 0.14 | 0.43 |
| AME | 8.54 | 2.47 | 15.18 | 10 | 0.85 | 1.124 |
| AOH | 207 | < LOQ | 1213 | 29 | 59.50 | 59.73 |
| βZAL | 23.22 | 22.59 | 23.85 | 3 | 0.58 | 2.86 |
| HT2 | 22.76 | 21.38 | 24.15 | 3 | 0.57 | 1.13 |
| OTA | 5.43 | 2.93 | 10.81 | 9 | 0.48 | 0.75 |
| PAT | 28.18 | < LOQ | 50.95 | 18 | 4.93 | 6.9 |
a Lower bound scenario: Mean assigning zero to not detected mycotoxins or mycotoxins detected below their corresponding LOQ. b Upper bound scenario: Mean assigning the LOD to not detected mycotoxins, and the corresponding LOQ to mycotoxins detected at levels below LOQ.
Figure 1Chromatograms of contaminated samples with (a) patulin (PAT) (28.37 µg/L) and (b) AOH (441.5 µg/L) determined by GC-MS/MS and LC-MS/MS, respectively.
Sum of mycotoxins concentrations in multi-contaminated samples (µg/L).
| Mycotoxins Co-occurrence | Number of Samples | Sum of Concentrations |
|---|---|---|
| AOH + β-ZAL (apple juice) | 1 | 24.86 |
| ΒZAL + PAT (apple juice) | 1 | 50.96 |
| AOH + AME+AFB1 (pineapple juice, peach juice) | 3 | 9.36–36.2 |
| AME + AFB2 + AFG2 + OTA + PAT (fresh orange juice) | 1 | 33.3 |
| AME + AFB1 + AFB2 + OTA + PAT (fresh orange juice) | 1 | 71.33 |
| AOH + AME + AFB1 + AFB2 + AFG2 + OTA + PAT (fresh orange juice) | 2 | 65.47–97.36 |
Mycotoxin incidence, concentration range and mean of positive samples (µg/L).
| Mycotoxin | Mono-Fruit Juices (n = 40) | Blended Beverages (n = 40) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresh Orange Juices (n = 7) | Packed Juices (n = 33) | Ecological Label (n = 5) | Health Claims Label (n = 24) | Common Label (n = 11) | |||||||||||
| I a | Mean ± SD µg/L | Range µg/L | I | Mean ± SD µg/L | Range µg/L | I | Mean ± SD µg/L | Range µg/L | I | Mean ± SD µg/L | Range µg/L | I | Mean ± SD µg/L | Range µg/L | |
| AFB1 | 3/7 | 9.37 ± 3.03 | 5.93–11.65 | 3/33 | 9.77 ± 7.3 | 4.68–18.1 | nd | --- | -- | nd | -- | -- | nd | -- | -- |
| AFB2 | 5/7 | 4.49 ± 4.53 | 1.38–12.49 | nd | --- | -- | nd | --- | -- | nd | --- | -- | nd | --- | -- |
| AFG2 | 3/7 | 3.76 ± 3.4 | 1.24–7.6 | nd | --- | -- | nd | --- | -- | nd | --- | -- | nd | --- | -- |
| AME | 5/7 | 9.53 ± 2.05 | 7.03–11.77 | 3/33 | 6.87 ± 7.2 | 2.47–15.18 | nd | --- | -- | nd | --- | -- | nd | --- | -- |
| AOH | 2/7 | 3.59 ± 3.14 | 1.37–5.81 | 11/33 | 3.71 ± 3.55 | <LOQ–11.16 | 2/5 | 629.74 ± 266 | 441.5–817.98 | 8/24 | 528.01 ± 362.9 | 93.5–1213.87 | nd | --- | -- |
| Β-ZAL | nd b | --- | -- | 2/33 | 23.22 ± 0.89 | 22.59–23.85 | nd | --- | -- | nd | --- | -- | nd | --- | -- |
| HT2 | nd | --- | -- | nd | --- | -- | nd | --- | -- | nd | --- | -- | 2/11 | 22.77 ± 1.95 | 21.38–24.15 |
| OTA | 5/7 | 6.25 ± 3.93 | 2.93–10.81 | 2/33 | 3.4 ± 0.38 | 3.13–3.67 | nd | --- | -- | nd | --- | -- | nd | --- | -- |
| PAT | 7/7 | 34.59 ± 13.9 | 14.78–50.59 | 5/33 | 28.34 ± 14 | 8.05–47.82 | nd | --- | -- | nd | --- | -- | 2/11 | 10.89 ± 0 | <LOQ–10.89 |
a Incidence (number positive samples/number total samples). b not detected.
Mycotoxin risk assessment through fruit juices consumption for children and adult population.
| Mycotoxin | TDI (ng/kg bw) | Positive Samples | Lower Bound Scenario | Upper Bound Scenario | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EDI (ng/kg bw) | %TDI | EDI (ng/kg bw) | %TDI | EDI (ng/kg bw) | %TDI | ||||||||
| Children | Adults | Children | Adults | Children | Adults | Children | Adults | Children | Adults | Children | Adults | ||
| PAT | 400 | 225.44 | 10.15 | 56.36 | 2.54 | 39.20 | 1.76 | 9.80 | 0.44 | 55.20 | 2.48 | 13.80 | 0.62 |
| OTA | 17 | 43.44 | 1.96 | 255.53 | 11.50 | 3.84 | 0.17 | 22.59 | 1.02 | 6.00 | 0.27 | 35.29 | 1.59 |
| B-ZAL | 250 | 185.76 | 8.36 | 74.30 | 3.34 | 4.64 | 0.21 | 1.86 | 0.08 | 22.88 | 1.03 | 9.15 | 0.41 |
| HT-2 | 100 | 182.08 | 8.20 | 182.08 | 8.20 | 4.56 | 0.21 | 4.56 | 0.21 | 9.04 | 0.41 | 9.04 | 0.41 |